2011 and Specialization - Primary Care Digest

Diabetes related complications among Ethiopian Jews-Outcomes of a 10 years cohort study in Israel [Population health and epidemiology]

Annals of Family Medicine

NOVEMBER 20, 2024

Population: Jewish CHS members, aged 18+, diagnosed with T2D between 2000-2011, born in Israel or Ethiopia. Conclusions: It is imperative to provide specialized care for immigrant populations to enhance the management of chronic diseases and mitigate further morbidity risks. Intervention: 10-year follow-up to track T2D outcomes.

Complication

Complication Diabetes Individual Chronic Disease

Jennifer Newberger Returns to HPM as a Director After Stints with Apple, Abbott Laboratories, and Cognito Therapeutics

FDA Law Blog

MAY 27, 2024

She also specializes in medical device software and digital health. Jennifer was with the firm from 2011-2017, before leaving for in-house roles at Apple, Abbott Laboratories, and Cognito Therapeutics. Jennifer also helps clients with contract matters, regulatory due diligence, and public filings. Ellison, Managing Director at HPM.

Manufacturing

Manufacturing Management Utilities Relationship

I Hear You Knockin’… Preparing for and Managing DEA Inspections (Part 1)

FDA Law Blog

MAY 3, 2021

However, more recently, we have observed that DEA special agents are also becoming more involved in investigations of registrants, thus, raising the stakes for compliance. 39,318 , 39,324 (July 6, 2011). 6 (2011) (statement of Michele M. We will discuss these actions in more detail in later blog.

Management

Management Manufacturing Specialization IT

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

DECEMBER 16, 2020

2011 Sep 20;155(6):408]. Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology [published correction appears in J Am Coll Cardiol. Ann Intern Med. 2009;150(9):604-612.

Clinic

Clinic Education Clinical Practice Patient-Centered

I Hear You Knockin’… Preparing for and Managing DEA Inspections (Part 1)

FDA Law Blog

MAY 3, 2021

However, more recently, we have observed that DEA special agents are also becoming more involved in investigations of registrants, thus, raising the stakes for compliance. 39,318 , 39,324 (July 6, 2011). 6 (2011) (statement of Michele M. We will discuss these actions in more detail in later blog.

Management

Management Manufacturing Specialization IT

Texas invests $50M in psychedelic drug research to treat addiction

Medical Xpress

JUNE 16, 2025

Explore further Trials using psychedelic drug to treat trauma, addiction endorsed by Texas Legislature shares Facebook Twitter Email Feedback to editors Featured Last Comments Popular Decades after 9/11, PTSD remains a persistent burden for thousands of responders 3 hours ago 0 A single enzymatic switch steers cell fate in intestinal regeneration Jun (..)

Mental Health

Mental Health IT Medical Specialization

Rewiring the body clock: Deep brain imaging reveals unexpected complexity in jet lag adjustment

Medical Xpress

JUNE 16, 2025

What is known is that special cells in the eye called intrinsically photosensitive retinal ganglion cells (ipRGCs) detect blue light and send signals to the SCN to reset the clock. But what happens inside the SCN after receiving this light signal has remained largely mysterious—until now.

Provider

Provider Medical Complication Diabetes

CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program

FDA Law Blog

DECEMBER 3, 2023

As part of this change, the Coverage Gap Discount Program (CGDP), a program that has existed since 2011, will sunset on December 31, 2024, and be replaced by the Medicare Part D Manufacturer Discount Program (the “Discount Program”). CMS also provides manufacturers a “special opportunity” to get a preliminary (i.e.,

Manufacturing

Manufacturing Provider IT Electronics

Skinny Label and Induced Infringement: The Saga Continues

FDA Law Blog

MAY 11, 2023

No reasonable jury could have concluded that the carved-out labeling for petitioner’s generic carvedilol from 2007-2011 was itself evidence of intent to induce infringement.” Plainly, the Government brief states “The decision below is incorrect. Whether the Court takes up Teva v. GSK is still up in the air.

Government

Government Manufacturing IT Utilities

Buprenorphine Use in Serious Illness: A Podcast with Katie Fitzgerald Jones, Zachary Sager and Janet Ho

GeriPal

APRIL 14, 2022

We got some really special guests with us. And so that lends it properties of being a pretty strong analgesic and it lends its special properties for safety, from a safety profile. I always thought this article came out 2011. Management of chronic pain in the elderly: focus on transdermal buprenorphine. Transcript.

Illness

Illness Patient-Centered IT Patients

Writing for the Lay Public: Rosanne Leipzig and Louise Aronson

GeriPal

MARCH 16, 2023

We have two authors, books, op-eds, prolific authors, and today’s podcast is a two-part special. I love his just because this is a palliative care audience in the article that then turned into being mortal, New Yorker, I don’t know, circa 2011 or something. Louise: I think that’s his MO. ” Or something.

IT

IT Healthcare Professional Healthcare Transportation

Exploring the Nature of Chronic Pain with Haider Warraich

GeriPal

JULY 7, 2022

Haider: Yeah, this is a special song. And then once I came to the United States, I saw this whole different dimension of pain, because I started residency in 2011, this was really at the peak of the opioid prescription epidemic, if you may. We’re going to be talking about pain and your book. But my editor cut it, to my dismay.

Patient-Centered

Patient-Centered Physicals IT Patients

FDA Announces it is Ready to Act on Menthol Cigarettes, but its Success is Uncertain

FDA Law Blog

MAY 14, 2021

In 2009, Congress specifically exempted “tobacco or menthol” when it prohibited all other flavored cigarettes under the Family Smoking Prevention and Tobacco Control Act (TCA)’s “ Special Rule for Cigarettes.” TPSAC released a report of its findings in 2011. at § 387g(d)(2). How will the flavored cigar ban affect premium cigars?

IT

IT Manufacturing Specialization Community

FDA Announces it is Ready to Act on Menthol Cigarettes, but its Success is Uncertain

FDA Law Blog

MAY 14, 2021

In 2009, Congress specifically exempted “tobacco or menthol” when it prohibited all other flavored cigarettes under the Family Smoking Prevention and Tobacco Control Act (TCA)’s “ Special Rule for Cigarettes.” TPSAC released a report of its findings in 2011. at § 387g(d)(2). How will the flavored cigar ban affect premium cigars?

IT

IT Manufacturing Specialization Community

Into the Ashtray: FDA’s Previous Proposal to Ban Menthol Cigarettes

FDA Law Blog

FEBRUARY 12, 2025

For some background (which is covered in more detail in one of our previous posts on the subject ), in 2009, Congress specifically exempted tobacco or menthol when it prohibited all other flavored cigarettes under the Family Smoking Prevention and Tobacco Control Act (TCA)s Special Rule for Cigarettes. 44,484 (July 24, 2013).

Specialization

Specialization IT Family Families

Primary Care Digest

Diabetes related complications among Ethiopian Jews-Outcomes of a 10 years cohort study in Israel [Population health and epidemiology]

Jennifer Newberger Returns to HPM as a Director After Stints with Apple, Abbott Laboratories, and Cognito Therapeutics

Trending Sources

I Hear You Knockin’… Preparing for and Managing DEA Inspections (Part 1)

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

I Hear You Knockin’… Preparing for and Managing DEA Inspections (Part 1)

Texas invests $50M in psychedelic drug research to treat addiction

Rewiring the body clock: Deep brain imaging reveals unexpected complexity in jet lag adjustment

CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program

Skinny Label and Induced Infringement: The Saga Continues

Buprenorphine Use in Serious Illness: A Podcast with Katie Fitzgerald Jones, Zachary Sager and Janet Ho

Writing for the Lay Public: Rosanne Leipzig and Louise Aronson

Exploring the Nature of Chronic Pain with Haider Warraich

FDA Announces it is Ready to Act on Menthol Cigarettes, but its Success is Uncertain

FDA Announces it is Ready to Act on Menthol Cigarettes, but its Success is Uncertain

Into the Ashtray: FDA’s Previous Proposal to Ban Menthol Cigarettes

Stay Connected